ID   PDPK1_RAT               Reviewed;         559 AA.
AC   O55173; G3V9W3;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2012, sequence version 2.
DT   02-OCT-2024, entry version 185.
DE   RecName: Full=3-phosphoinositide-dependent protein kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase B kinase;
DE            Short=PkB kinase;
GN   Name=Pdpk1; Synonyms=Pdk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9445477; DOI=10.1126/science.279.5351.710;
RA   Stephens L.R., Anderson K.E., Stokoe D., Erdjument-Bromage H.,
RA   Painter G.F., Holmes A.B., Gaffney P.R.J., Reese C.B., McCormick F.,
RA   Tempst P., Coadwell W.J., Hawkins P.T.;
RT   "Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-
RT   trisphosphate-dependent activation of protein kinase B.";
RL   Science 279:710-714(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15632090; DOI=10.1101/gr.2889405;
RA   Florea L., Di Francesco V., Miller J., Turner R., Yao A., Harris M.,
RA   Walenz B., Mobarry C., Merkulov G.V., Charlab R., Dew I., Deng Z.,
RA   Istrail S., Li P., Sutton G.;
RT   "Gene and alternative splicing annotation with AIR.";
RL   Genome Res. 15:54-66(2005).
RN   [4]
RP   FUNCTION IN PHOSPHORYLATION OF PRKCD AND PRKCZ, AUTOPHOSPHORYLATION, AND
RP   INTERACTION WITH PRKCD AND PRKCZ.
RX   PubMed=11781095; DOI=10.1021/bi010719z;
RA   Hodgkinson C.P., Sale G.J.;
RT   "Regulation of both PDK1 and the phosphorylation of PKC-zeta and -delta by
RT   a C-terminal PRK2 fragment.";
RL   Biochemistry 41:561-569(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine kinase which acts as a master kinase,
CC       phosphorylating and activating a subgroup of the AGC family of protein
CC       kinases (By similarity). Its targets include: protein kinase B
CC       (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase
CC       (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and
CC       RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase
CC       C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1,
CC       SGK2 and SGK3), p21-activated kinase-1 (PAK1), TSSK3, protein kinase
CC       PKN (PKN1 and PKN2) (PubMed:11781095). Plays a central role in the
CC       transduction of signals from insulin by providing the activating
CC       phosphorylation to PKB/AKT1, thus propagating the signal to downstream
CC       targets controlling cell proliferation and survival, as well as glucose
CC       and amino acid uptake and storage (By similarity). Negatively regulates
CC       the TGF-beta-induced signaling by: modulating the association of SMAD3
CC       and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4
CC       and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and
CC       the translocation of SMAD7 from the nucleus to the cytoplasm in
CC       response to TGF-beta (By similarity). Activates PPARG transcriptional
CC       activity and promotes adipocyte differentiation (By similarity).
CC       Activates the NF-kappa-B pathway via phosphorylation of IKKB (By
CC       similarity). The tyrosine phosphorylated form is crucial for the
CC       regulation of focal adhesions by angiotensin II (By similarity).
CC       Controls proliferation, survival, and growth of developing pancreatic
CC       cells (By similarity). Participates in the regulation of Ca(2+) entry
CC       and Ca(2+)-activated K(+) channels of mast cells (By similarity).
CC       Essential for the motility of vascular endothelial cells (ECs) and is
CC       involved in the regulation of their chemotaxis (By similarity). Plays a
CC       critical role in cardiac homeostasis by serving as a dual effector for
CC       cell survival and beta-adrenergic response (By similarity). Plays an
CC       important role during thymocyte development by regulating the
CC       expression of key nutrient receptors on the surface of pre-T cells and
CC       mediating Notch-induced cell growth and proliferative responses (By
CC       similarity). Provides negative feedback inhibition to toll-like
CC       receptor-mediated NF-kappa-B activation in macrophages (By similarity).
CC       {ECO:0000250|UniProtKB:O15530, ECO:0000250|UniProtKB:Q9Z2A0,
CC       ECO:0000269|PubMed:11781095}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Homodimerization regulates its activity by
CC       maintaining the kinase in an autoinhibitory conformation. NPRL2 down-
CC       regulates its activity by interfering with tyrosine phosphorylation at
CC       the Tyr-9, Tyr-376 and Tyr-379 residues. The 14-3-3 protein YWHAQ acts
CC       as a negative regulator by association with the residues surrounding
CC       the Ser-244 residue. STRAP positively regulates its activity by
CC       enhancing its autophosphorylation and by stimulating its dissociation
CC       from YWHAQ. SMAD2, SMAD3, SMAD4 and SMAD7 also positively regulate its
CC       activity by stimulating its dissociation from YWHAQ. Activated by
CC       phosphorylation on Tyr-9, Tyr-376 and Tyr-379 by INSR in response to
CC       insulin (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer in its autoinhibited state. Active as monomer.
CC       Interacts with NPRL2, PPARG, PAK1, PTK2B, GRB14, PKN1 (via C-terminus),
CC       STRAP and IKKB. The Tyr-9 phosphorylated form interacts with SRC, RASA1
CC       and CRK (via their SH2 domains). Interacts with SGK3 in a
CC       phosphorylation-dependent manner. The tyrosine-phosphorylated form
CC       interacts with PTPN6. The Ser-244 phosphorylated form interacts with
CC       YWHAH and YWHAQ. Binds INSR in response to insulin. Interacts (via PH
CC       domain) with SMAD3, SMAD4 and SMAD7 (By similarity). Interacts with
CC       PKN2; the interaction stimulates PDPK1 autophosphorylation, its
CC       PI(3,4,5)P3-dependent kinase activity toward 'Ser-473' of AKT1 but also
CC       activates its kinase activity toward PRKCD and PRKCZ. {ECO:0000250,
CC       ECO:0000269|PubMed:11781095}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC       Cell junction, focal adhesion {ECO:0000250}. Note=Tyrosine
CC       phosphorylation seems to occur only at the cell membrane. Translocates
CC       to the cell membrane following insulin stimulation by a mechanism that
CC       involves binding to GRB14 and INSR. SRC and HSP90 promote its
CC       localization to the cell membrane. Its nuclear localization is
CC       dependent on its association with PTPN6 and its phosphorylation at Ser-
CC       396. Restricted to the nucleus in neuronal cells while in non-neuronal
CC       cells it is found in the cytoplasm. The Ser-244 phosphorylated form is
CC       distributed along the perinuclear region in neuronal cells while in
CC       non-neuronal cells it is found in both the nucleus and the cytoplasm.
CC       IGF1 transiently increases phosphorylation at Ser-244 of neuronal
CC       PDPK1, resulting in its translocation to other cellular compartments.
CC       The tyrosine-phosphorylated form colocalizes with PTK2B in focal
CC       adhesions after angiotensin II stimulation (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The PH domain plays a pivotal role in the localization and
CC       nuclear import of PDPK1 and is also essential for its homodimerization.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The PIF-pocket is a small lobe in the catalytic domain required
CC       by the enzyme for the binding to the hydrophobic motif of its
CC       substrates. It is an allosteric regulatory site that can accommodate
CC       small compounds acting as allosteric inhibitors.
CC       {ECO:0000250|UniProtKB:O15530}.
CC   -!- PTM: Phosphorylation on Ser-244 in the activation loop is required for
CC       full activity. PDPK1 itself can autophosphorylate Ser-244, leading to
CC       its own activation. Autophosphorylation is inhibited by the apoptotic
CC       C-terminus cleavage product of PKN2. Tyr-9 phosphorylation is critical
CC       for stabilization of both PDPK1 and the PDPK1/SRC complex via HSP90-
CC       mediated protection of PDPK1 degradation. Angiotensin II stimulates the
CC       tyrosine phosphorylation of PDPK1 in vascular smooth muscle in a
CC       calcium- and SRC-dependent manner. Phosphorylated on Tyr-9, Tyr-376 and
CC       Tyr-379 by INSR in response to insulin. Palmitate negatively regulates
CC       autophosphorylation at Ser-244 and palmitate-induced phosphorylation at
CC       Ser-532 and Ser-504 by PKC/PRKCQ negatively regulates its ability to
CC       phosphorylate PKB/AKT1. Phosphorylation at Thr-357 by MELK partially
CC       inhibits kinase activity, the inhibition is cooperatively enhanced by
CC       phosphorylation at Ser-397 and Ser-401 by MAP3K5 (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Monoubiquitinated in the kinase domain, deubiquitinated by USP4.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PDPK1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y15748; CAA75758.1; -; mRNA.
DR   EMBL; CH473948; EDM03805.1; -; Genomic_DNA.
DR   RefSeq; NP_112343.1; NM_031081.1.
DR   AlphaFoldDB; O55173; -.
DR   SMR; O55173; -.
DR   CORUM; O55173; -.
DR   STRING; 10116.ENSRNOP00000061683; -.
DR   iPTMnet; O55173; -.
DR   PhosphoSitePlus; O55173; -.
DR   jPOST; O55173; -.
DR   PaxDb; 10116-ENSRNOP00000061683; -.
DR   Ensembl; ENSRNOT00000067660.2; ENSRNOP00000061683.1; ENSRNOG00000006136.6.
DR   Ensembl; ENSRNOT00055045426; ENSRNOP00055037224; ENSRNOG00055026228.
DR   Ensembl; ENSRNOT00060016542; ENSRNOP00060012928; ENSRNOG00060009727.
DR   Ensembl; ENSRNOT00065016490; ENSRNOP00065012535; ENSRNOG00065010212.
DR   GeneID; 81745; -.
DR   KEGG; rno:81745; -.
DR   UCSC; RGD:620307; rat.
DR   AGR; RGD:620307; -.
DR   CTD; 5170; -.
DR   RGD; 620307; Pdpk1.
DR   eggNOG; KOG0592; Eukaryota.
DR   GeneTree; ENSGT00940000155267; -.
DR   HOGENOM; CLU_000288_63_9_1; -.
DR   InParanoid; O55173; -.
DR   OrthoDB; 208777at2759; -.
DR   TreeFam; TF105423; -.
DR   BRENDA; 2.7.11.1; 5301.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-165158; Activation of AKT2.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-2730905; Role of LAT2/NTAL/LAB on calcium mobilization.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-RNO-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-RNO-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-RNO-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-RNO-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-RNO-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-RNO-9634635; Estrogen-stimulated signaling through PRKCZ.
DR   PRO; PR:O55173; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Bgee; ENSRNOG00000006136; Expressed in testis and 19 other cell types or tissues.
DR   GO; GO:0042995; C:cell projection; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0004676; F:3-phosphoinositide-dependent protein kinase activity; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005158; F:insulin receptor binding; IDA:RGD.
DR   GO; GO:0016004; F:phospholipase activator activity; ISO:RGD.
DR   GO; GO:0043274; F:phospholipase binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:1990416; P:cellular response to brain-derived neurotrophic factor stimulus; IEP:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:RGD.
DR   GO; GO:0006972; P:hyperosmotic response; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0034122; P:negative regulation of toll-like receptor signaling pathway; ISO:RGD.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISO:RGD.
DR   GO; GO:1905564; P:positive regulation of vascular endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0043122; P:regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0010594; P:regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0043304; P:regulation of mast cell degranulation; ISO:RGD.
DR   GO; GO:0003323; P:type B pancreatic cell development; ISO:RGD.
DR   CDD; cd01262; PH_PDK1; 1.
DR   CDD; cd05581; STKc_PDK1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR033931; PDK1-typ_PH.
DR   InterPro; IPR039046; PDPK1.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050236; Ser_Thr_kinase_AGC.
DR   PANTHER; PTHR24356:SF163; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1-RELATED; 1.
DR   PANTHER; PTHR24356; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   Pfam; PF14593; PH_3; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell junction; Cell membrane; Cytoplasm; Kinase;
KW   Membrane; Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..559
FT                   /note="3-phosphoinositide-dependent protein kinase 1"
FT                   /id="PRO_0000086502"
FT   DOMAIN          85..345
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          462..553
FT                   /note="PH"
FT   REGION          25..83
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..160
FT                   /note="PIF-pocket"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   COMPBIAS        25..69
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        208
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         95..97
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   BINDING         114
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   BINDING         163..165
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   BINDING         169
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   BINDING         212
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   BINDING         226
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         9
FT                   /note="Phosphotyrosine; by SRC and INSR"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         307
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2A0"
FT   MOD_RES         357
FT                   /note="Phosphothreonine; by MELK"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         376
FT                   /note="Phosphotyrosine; by SRC and INSR"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         379
FT                   /note="Phosphotyrosine; by SRC and INSR"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         396
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         397
FT                   /note="Phosphoserine; by MAP3K5"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         401
FT                   /note="Phosphoserine; by MAP3K5"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         504
FT                   /note="Phosphoserine; by PKC/PRKCQ"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2A0"
FT   MOD_RES         516
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O15530"
FT   MOD_RES         532
FT                   /note="Phosphoserine; by PKC/PRKCQ"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2A0"
FT   CONFLICT        401
FT                   /note="S -> C (in Ref. 1; CAA75758)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   559 AA;  63593 MW;  4D06A17F769B800F CRC64;
     MARTTSQLYD AVPIQSSVVL CSCPSPSMVR SQTEPSSSPG IPSGVSRQGS TMDGTTAEAR
     PSTNPLQQHP AQLPPQPRKK RPEDFKFGKI LGEGSFSTVV LARELATSRE YAIKILEKRH
     IIKENKVPYV TRERDVMSRL DHPFFVKLYF TFQDDEKLYF GLSYAKNGEL LKYIRKIGSF
     DETCTRFYTA EIVSALEYLH GKGIIHRDLK PENILLNEDM HIQITDFGTA KVLSPDSKQA
     RANSFVGTAQ YVSPELLTEK SACKSSDLWA LGCIIYQLVA GLPPFRAGNE YLIFQKIIKL
     EYDFPEKFFP KARDLVEKLL VLDATKRLGC EEMEGYGPLK AHPFFESITW ENLHQQTPPK
     LTAYLPAMSE DDEDCYGNYD NLLSQFGCMQ VSSSSSSHSL SAVDASLPQR SGSNIEQYIH
     DLDTNSFELD LQFSEDEKRL LLEKQAGGNP WHQFVENNLI LKMGPVDKRK GLFARRRQLL
     LTEGPHLYYV DPVNKVLKGE IPWSQELRPE AKNFKTFFVH TPNRTYYLMD PSGNAHKWCR
     KIQEVWRQQY QSSPDAAVQ
//
